PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1596088
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1596088
Portable Minimally Invasive Surgery Simulators Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)
Market Overview
The global portable minimally invasive surgery (MIS) simulators market is projected to reach $220.2 million in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 13.9% during the forecast period from 2024 to 2030. By 2030, the market value is anticipated to reach $479.9 million.
This robust growth is driven by increasing awareness of simulation-based learning and the widespread adoption of laparoscopic simulation systems. Technological advancements in portable MIS simulators and the growing demand for minimally invasive treatments further propel market expansion.
The COVID-19 pandemic emphasized the need for virtual training solutions as traditional surgical education activities faced disruptions. Governments worldwide have promoted virtual training via portable MIS simulators to ensure continuous learning for surgeons and medical professionals.
Key Insights
The market is segmented by type into endoscopic and cardiac simulators. Endoscopic simulators are expected to witness the fastest growth due to the rising number of endoscopic surgeries, which are preferred for their minimally invasive nature, shorter recovery times, and cost-effectiveness. Cardiac simulators hold a significant share, driven by the increasing prevalence of cardiovascular diseases. These simulators play a critical role in providing specialized training for complex cardiac procedures.
In terms of end-users, the market includes academic institutes, medical training centers, hospitals, and surgical clinics. Medical training centers lead the market, offering hands-on training to medical professionals. Hospitals and surgical clinics are also key contributors, focusing on skill development for practicing surgeons.
North America dominates the portable MIS simulators market, supported by advanced healthcare infrastructure, high adoption of innovative technologies, and the presence of major market players. The Asia-Pacific region is expected to experience the fastest growth during the forecast period, attributed to the increasing number of surgical procedures, rising healthcare investments, and growing awareness of simulation-based training among healthcare professionals.
Technological advancements are significantly shaping the market. The integration of virtual reality (VR) and augmented reality (AR) has enhanced the realism and effectiveness of surgical simulations, offering immersive learning experiences. Artificial intelligence (AI) and machine learning algorithms are being incorporated to provide personalized feedback and performance assessments, improving training outcomes for medical professionals.
The market is characterized by consolidation, with key players focusing on strategic initiatives like mergers, acquisitions, and partnerships to expand their product offerings. The emphasis on patient safety and the growing demand for minimally invasive procedures present opportunities for innovation and market growth. As healthcare facilities prioritize effective training, the adoption of advanced simulation technologies is expected to increase, driving the market forward.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by end user
- 1.4.3. Market size breakdown, by region
- 1.4.4. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Type (2019-2030)
- 6.3. Market Revenue, by End User (2019-2030)
- 6.4. Market Revenue, by Region (2019-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Type (2019-2030)
- 7.3. Market Revenue, by End User (2019-2030)
- 7.4. Market Revenue, by Country (2019-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Type (2019-2030)
- 8.3. Market Revenue, by End User (2019-2030)
- 8.4. Market Revenue, by Country (2019-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Type (2019-2030)
- 9.3. Market Revenue, by End User (2019-2030)
- 9.4. Market Revenue, by Country (2019-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Type (2019-2030)
- 10.3. Market Revenue, by End User (2019-2030)
- 10.4. Market Revenue, by Country (2019-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Type (2019-2030)
- 11.3. Market Revenue, by End User (2019-2030)
- 11.4. Market Revenue, by Country (2019-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Type (2019-2030)
- 12.3. Market Revenue, by End User (2019-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Type (2019-2030)
- 13.3. Market Revenue, by End User (2019-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Type (2019-2030)
- 14.3. Market Revenue, by End User (2019-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Type (2019-2030)
- 15.3. Market Revenue, by End User (2019-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Type (2019-2030)
- 16.3. Market Revenue, by End User (2019-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Type (2019-2030)
- 17.3. Market Revenue, by End User (2019-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Type (2019-2030)
- 18.3. Market Revenue, by End User (2019-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Type (2019-2030)
- 19.3. Market Revenue, by End User (2019-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Type (2019-2030)
- 20.3. Market Revenue, by End User (2019-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Type (2019-2030)
- 21.3. Market Revenue, by End User (2019-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Type (2019-2030)
- 22.3. Market Revenue, by End User (2019-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Type (2019-2030)
- 23.3. Market Revenue, by End User (2019-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Type (2019-2030)
- 24.3. Market Revenue, by End User (2019-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Type (2019-2030)
- 25.3. Market Revenue, by End User (2019-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Type (2019-2030)
- 26.3. Market Revenue, by End User (2019-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Type (2019-2030)
- 27.3. Market Revenue, by End User (2019-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Type (2019-2030)
- 28.3. Market Revenue, by End User (2019-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. CAE Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. 3-Dmed
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Surgical Science Sweden AB
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Olympus Corporation
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. VirtaMed AG
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Inovus Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Mentice AB
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. MEDICAL-X
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. eoSurgical Ltd.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Laparo Sp. z.o.o.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
- 30.11. CATHI GmbH
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
- 30.12. K.K. MedVision
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
